SR ONE CAPITAL MANAGEMENT, LLC
Related Filers (10)
- Arcellx, Inc. (10)
- SR One Capital Fund I Aggregator LP (8)
- SR ONE CAPITAL PARTNERS I, LP (8)
- George Simeon (5)
- eFFECTOR Therapeutics, Inc. (4)
- Design Therapeutics, Inc. (3)
- SR One Co-Invest II, LLC (3)
- SR One Co-Invest II Manager, LLC (2)
- SR One Co-Invest I, LLC (2)
- SR One Co-Invest I Manager, LLC (2)
- Show More ...
Other (2)
144
Thursday, 5/11/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 5/11/2023
Filing for proposed sale of securities under Rule 144
Ownership (15)
SC 13G/A
Friday, 2/9/2024
eFFECTOR Therapeutics, Inc.: Major Shareholders
SC 13D/A
Monday, 12/18/2023
Arcellx, Inc.: Major Shareholders
4
Wednesday, 11/29/2023
eFFECTOR Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 6/2/2023
Arcellx, Inc.: Major Shareholders
SC 13D/A
Friday, 5/19/2023
Arcellx, Inc.: Major Shareholders
4
Monday, 5/15/2023
Arcellx, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/20/2022
Design Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 6/27/2022
Arcellx, Inc.: Major Shareholders
SC 13D
Thursday, 2/17/2022
Arcellx, Inc.: Major Shareholders
SC 13G
Monday, 2/14/2022
eFFECTOR Therapeutics, Inc.: Major Shareholders
4
Thursday, 2/10/2022
Arcellx, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 2/3/2022
Arcellx, Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 9/2/2021
eFFECTOR Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 4/1/2021
Design Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3/A
Tuesday, 3/30/2021
Design Therapeutics, Inc.: Initial statement of beneficial ownership of securities